700015007: Eslicarbazepine acetate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with cytochrome P450 inhibitor mechanism of action (substance)\Cytochrome P450 2C19 inhibitor\Eslicarbazepine acetate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Anticonvulsant\Eslicarbazepine acetate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Eslicarbazepine acetate

\Organic compound\Organic nitrogen compound\Eslicarbazepine acetate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2987348013 Eslicarbazepine acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2987374019 Eslicarbazepine acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4843231000005115 eslicarbazepinacetat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Eslicarbazepine acetate	Is a	Eslicarbazepine	false	Inferred relationship	Some
Eslicarbazepine acetate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Cytochrome P450 2C19 inhibitor	true	Inferred relationship	Some
Eslicarbazepine acetate	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Eslicarbazepine acetate	Is a	Anticonvulsant	true	Inferred relationship	Some
Eslicarbazepine acetate	Is a	Cytochrome P450 2C19 inhibitor	true	Inferred relationship	Some
Eslicarbazepine acetate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Eslicarbazepine	true	Inferred relationship	Some
Eslicarbazepine acetate	Is a	Organic nitrogen compound	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely eslicarbazepine acetate 200 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 200 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 800 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 800 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Eslicarbazepine acetate 50 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Eslicarbazepine acetate 50 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 400 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Product containing precisely eslicarbazepine acetate 400 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Eslicarbazepine acetate 600 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Eslicarbazepine acetate	Inferred relationship	Some	1
Eslicarbazepine acetate 600 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Eslicarbazepine acetate	Inferred relationship	Some	1

This concept is not in any reference sets